Scarica l'app Stockscreener
1.43
0.70%
0.01
Dopo l'orario di chiusura:
1.40
-0.03
-2.10%
Precedente Chiudi:
$1.42
Aprire:
$1.41
Volume 24 ore:
95,057
Relative Volume:
0.51
Capitalizzazione di mercato:
$44.61M
Reddito:
$81,000
Utile/perdita netta:
$-41.04M
Rapporto P/E:
-1.0859
EPS:
-1.3169
Flusso di cassa netto:
$-30.69M
1 W Prestazione:
-14.37%
1M Prestazione:
-10.63%
6M Prestazione:
-5.92%
1 anno Prestazione:
-20.56%
Intervallo 1D:
$1.40
$1.44
Intervallo di 1 settimana:
$1.40
$1.69
Portata 52W:
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Nome
Actinium Pharmaceuticals Inc
Settore
Industria
Telefono
646-767-3870
Indirizzo
275 Madison Avenue, 7th Floor, New York, NY
Confronta ATNM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.43 | 44.30M | 81,000 | -41.04M | -30.69M | -1.3169 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-07 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Iniziato | B. Riley Securities | Buy |
| 2020-11-05 | Iniziato | Alliance Global Partners | Buy |
| 2017-12-06 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Ripresa | ROTH Capital | Buy |
| 2017-09-14 | Iniziato | Maxim Group | Buy |
| 2016-08-25 | Iniziato | ROTH Capital | Buy |
| 2016-02-29 | Iniziato | H.C. Wainwright | Buy |
| 2015-10-15 | Iniziato | FBR Capital | Outperform |
| 2014-10-01 | Iniziato | MLV & Co | Buy |
| 2014-07-22 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie
How Actinium Pharmaceuticals Inc. stock performs in rate cut cycles2025 Price Momentum & Community Verified Trade Alerts - newser.com
How supply shortages influence Actinium Pharmaceuticals Inc. (Delaware) stock2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Identifying reversal signals in Actinium Pharmaceuticals Inc.July 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
Is Actinium Pharmaceuticals Inc. stock a smart buy before Fed meeting2025 Top Gainers & Verified Momentum Stock Alerts - newser.com
Will Actinium Pharmaceuticals Inc. (7AY1) stock outperform foreign stocksEntry Point & Weekly Breakout Opportunity Watchlist - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock expands through international markets2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedMarket Volume Summary & AI Based Buy and Sell Signals - newser.com
Is Actinium Pharmaceuticals Inc. stock ready for a breakoutQuarterly Market Review & Real-Time Volume Trigger Notifications - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock responds to bond marketJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
Is Actinium Pharmaceuticals Inc. stock entering bullish territoryEarnings Growth Report & Safe Capital Growth Tips - newser.com
Will Actinium Pharmaceuticals Inc. (7AY1) stock gain from lower interest ratesQuarterly Market Summary & Community Consensus Trade Alerts - newser.com
Published on: 2025-10-31 04:06:04 - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock stacks up against competitorsPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Can you recover from losses in Actinium Pharmaceuticals Inc.July 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Is Actinium Pharmaceuticals Inc. (Delaware) stock a buy on weaknessWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-10-30 03:05:03 - newser.com
Published on: 2025-10-29 21:28:17 - newser.com
Is Actinium Pharmaceuticals Inc. (7AY1) stock trading at attractive multiples2025 Price Momentum & Technical Confirmation Trade Alerts - fcp.pa.gov.br
Institution Moves: How Actinium Pharmaceuticals Inc. stock benefits from tech adoption2025 Biggest Moves & Safe Entry Zone Identification - fcp.pa.gov.br
Published on: 2025-10-27 22:12:19 - fcp.pa.gov.br
Actinium Announces Superior Anti-Tumor Activity of ATNM-400 in Lung Cancer Compared to the Leading First, Second and Third-Line Approved EGFR Mutant Therapies and Mechanistic Synergy with Osimertinib at the AACR-NCI-EORTC International Confer - PR Newswire
Actinium Pharmaceuticals Inc Azioni (ATNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):